NasdaqGM - Nasdaq Real Time Price USD
Avidity Biosciences, Inc. (RNA)
26.03
-0.23
(-0.88%)
As of 11:16:03 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 14 | 13 |
| Avg. Estimate | -0.88 | -0.92 | -3.82 | -4.3 |
| Low Estimate | -1.07 | -1.18 | -4.99 | -5.77 |
| High Estimate | -0.55 | -0.57 | -2.38 | -2.34 |
| Year Ago EPS | -0.79 | -0.65 | -2.89 | -3.82 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 11 | 10 |
| Avg. Estimate | 2.62M | 2.51M | 8.35M | 18.8M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 5.3M | 5.3M | 21M | 77.7M |
| Year Ago Sales | 3.54M | 2.04M | 10.9M | 8.35M |
| Sales Growth (year/est) | -25.92% | 22.77% | -23.41% | 125.27% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.88 | -0.78 | -0.72 | -0.78 |
| EPS Actual | -0.79 | -0.65 | -0.65 | -0.8 |
| Difference | 0.09 | 0.13 | 0.07 | -0.02 |
| Surprise % | 9.79% | 17.12% | 9.52% | -2.45% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.88 | -0.92 | -3.82 | -4.3 |
| 7 Days Ago | -0.88 | -0.92 | -3.82 | -4.3 |
| 30 Days Ago | -0.88 | -0.92 | -3.82 | -4.3 |
| 60 Days Ago | -0.91 | -0.96 | -3.96 | -4.74 |
| 90 Days Ago | -0.77 | -0.79 | -3.16 | -3.57 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 2 | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 8 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RNA | -11.43% | -40.85% | -32.24% | -12.51% |
| S&P 500 | 12.38% | 3.18% | 8.00% | 13.86% |
Upgrades & Downgrades
| Maintains | Chardan Capital: Buy to Buy | 5/7/2025 |
| Reiterates | Needham: Buy to Buy | 4/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/18/2025 |
| Reiterates | Needham: Buy to Buy | 3/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/17/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/17/2025 |
Related Tickers
ACLX Arcellx, Inc.
52.05
-1.42%
DYN Dyne Therapeutics, Inc.
9.33
-6.94%
PCVX Vaxcyte, Inc.
29.06
-0.63%
KRYS Krystal Biotech, Inc.
136.37
-2.22%
CYTK Cytokinetics, Incorporated
33.25
-2.12%
PTCT PTC Therapeutics, Inc.
39.71
+9.73%
AKRO Akero Therapeutics, Inc.
42.30
+0.65%
MRUS Merus N.V.
39.11
-0.85%
CRNX Crinetics Pharmaceuticals, Inc.
30.89
+1.21%
BBIO BridgeBio Pharma, Inc.
35.89
-2.86%